Concepedia

Tizita Zeleke

TZ

5

Publications

250

Citations

5

H-Index

2016

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Mount Sinai Hospital

St. Jude Children's Research Hospital

Tizita Zeleke is an author at Icahn School of Medicine at Mount Sinai specializing in radiation oncology, medicine, and cancer research.

Top concepts

Publications per year

2016–2023

5

Publications

5

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy

Ruth Rodríguez‐Barrueco, Erin A. Nekritz, François Bertucci et al. · Genes & Development · 2017 · 90 citations · Full text

, , +17

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Tizita Zeleke, Qingfei Pan, Codruța Chiuzan et al. · Nature Cancer · 2022 · 70 citations · Full text

, , +9

In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment

Hadassa Hirschfield, C. Billie Bian, Takaaki Higashi et al. · Experimental & Molecular Medicine · 2018 · 46 citations · Full text

The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options

Arpit Dave, Daniel Charytonowicz, Nancy Francoeur et al. · Cellular Oncology · 2023 · 27 citations · Full text

Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer

Mary Mazzotta Heckler, Tizita Zeleke, Shailaja D. Divekar et al. · Oncotarget · 2016 · 17 citations · Full text

Rows per page

1–5 of 5